1. Home
  2. RGEN vs THG Comparison

RGEN vs THG Comparison

Compare RGEN & THG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • THG
  • Stock Information
  • Founded
  • RGEN 1981
  • THG 1852
  • Country
  • RGEN United States
  • THG United States
  • Employees
  • RGEN N/A
  • THG N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • THG Property-Casualty Insurers
  • Sector
  • RGEN Health Care
  • THG Finance
  • Exchange
  • RGEN Nasdaq
  • THG Nasdaq
  • Market Cap
  • RGEN 7.1B
  • THG 5.8B
  • IPO Year
  • RGEN N/A
  • THG 1995
  • Fundamental
  • Price
  • RGEN $145.23
  • THG $163.89
  • Analyst Decision
  • RGEN Buy
  • THG Buy
  • Analyst Count
  • RGEN 12
  • THG 8
  • Target Price
  • RGEN $175.56
  • THG $178.00
  • AVG Volume (30 Days)
  • RGEN 953.7K
  • THG 292.1K
  • Earning Date
  • RGEN 04-29-2025
  • THG 04-30-2025
  • Dividend Yield
  • RGEN N/A
  • THG 2.23%
  • EPS Growth
  • RGEN N/A
  • THG 1093.97
  • EPS
  • RGEN N/A
  • THG 11.70
  • Revenue
  • RGEN $634,439,000.00
  • THG $6,237,400,000.00
  • Revenue This Year
  • RGEN $12.29
  • THG $5.97
  • Revenue Next Year
  • RGEN $15.20
  • THG $5.93
  • P/E Ratio
  • RGEN N/A
  • THG $13.81
  • Revenue Growth
  • RGEN 0.33
  • THG 4.07
  • 52 Week Low
  • RGEN $102.97
  • THG $119.66
  • 52 Week High
  • RGEN $182.52
  • THG $176.16
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 59.03
  • THG 51.31
  • Support Level
  • RGEN $125.05
  • THG $155.93
  • Resistance Level
  • RGEN $148.94
  • THG $165.44
  • Average True Range (ATR)
  • RGEN 10.09
  • THG 5.66
  • MACD
  • RGEN 3.52
  • THG 0.38
  • Stochastic Oscillator
  • RGEN 91.93
  • THG 75.13

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through three operating segments: Commercial Lines, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

Share on Social Networks: